| TELIX PHARMACEUTICALS LTD |
| Australien |
| Gesundheit |
| AU000000TLX2 / A2H7JK |
| T3X (Frankfurt) |
| FRA:T3X, ETR:T3X, T3X:GR |
| - |
| https://telixpharma.com/ |
|
Telix Pharmaceuticals Limited is a global, commercial-stage biopharmaceutical company specializing in the development and commercialization of targeted radiopharmaceuticals for oncology. Headquartered in Melbourne, Australia, Telix focuses on precisi..
>Volltext.. |
| 3454.58 Mio. EUR |
| 3729.16 Mio. EUR |
| 712.04 Mio. EUR |
| 34.73 Mio. EUR |
| -6.28 Mio. EUR |
| -0.02 EUR |
| 400.2 Mio. EUR |
| 121.54 Mio. EUR |
| -15.08 Mio. EUR |
| 0.61 |
| 51.27% |
| -120.93% |
| - |
| - |
| - |
| - |
| TELIX |
| 20.08.26 |
|